Journal of Commercial Biotechnology
| Discipline | Biotechnology |
|---|---|
| Language | English |
| Publication details | |
Publication history | 1992 to present |
| Publisher | |
| Standard abbreviations | |
| J. Commer. Biotechnol. | |
| Indexing | |
| ISSN |
1462-8732 (print) 1478-565X (web) |
| Links | |
The Journal of Commercial Biotechnology is a peer-reviewed academic journal covering the business of biotechnology. Topics covered include biotechnology management, policy, finance, law, and regulations.
The Journal of Commercial Biotechnology was founded by Henry Stewart Publications in 1992 as the Journal of Biotechnology in Healthcare,[1] and changed its name to the Journal of Commercial Biotechnology in 1998.[2] The journal was later published by Palgrave MacMillan[3] and was purchased by thinkBiotech[4] in 2010. It is published quarterly. An external Editorial Board assists with peer review. The current editor of the Journal of Commercial Biotechnology is Yali Friedman, who has served since 2007.
External links
References
- ↑ "Archived copy". Archived from the original on 2012-03-25. Retrieved 2011-06-21.
- ↑ http://www.worldcat.org/title/journal-of-commercial-biotechnology/oclc/41491559&referer=brief_results
- ↑ http://www.ingentaconnect.com/content/pal/jcb
- ↑ http://thinkbiotech.com/#products
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.